Rest Of Latin America Organ Preservation Market (2025-2030)
The Rest Of Latin America Organ Preservation Market was valued at $1.51 Million in 2025 and projected to reach to $1.81 Million by 2030, representing a compound annual growth rate of 3.7%. Rest of Latin America's organ preservation market is positioned for steady growth as healthcare systems continue modernizing and transplant infrastructure expands across the region.
Rest Of Latin America Organ Preservation Market Trends and Insights
- Rolatam represents a developing segment within the Latin American organ preservation landscape, where healthcare infrastructure investments and transplant program expansion are gradually increasing demand for advanced preservation technologies.
- The market in Rolatam is characterized by growing awareness of organ shortage challenges and incremental adoption of preservation solutions among transplant centers. During the 2025–2030 forecast period, Rolatam is expected to experience steady growth driven by improvements in healthcare funding and rising transplant volumes.
- Rolatam's organ preservation market remains smaller than global benchmarks but reflects regional efforts to modernize transplant capabilities.
- Key factors supporting Rolatam's market expansion include regulatory support for transplant programs, partnerships with international medical device suppliers, and increasing investment in organ procurement infrastructure across Rolatam's healthcare systems..
Key Market Statistics
- CAGR (2025-2030) 3.7% CAGR
- Market Size, 2025 ~USD 1.51 Million
- Forecast, 2030 ~USD 1.81 Million
- Country Rest Of Latin America
Rest Of Latin America Organ Preservation Market Overview
Market Size & Growth :
Rest of Latin America's organ preservation market is valued at USD 1.51 million in 2025, with projected growth to USD 1.81 million by 2030, representing a steady 3.7% CAGR despite being a developing segment within the region.
Healthcare Infrastructure Development :
Gradual investments in healthcare infrastructure across Rest of Latin America are driving adoption of organ preservation technologies, with emerging transplant programs creating new demand for advanced preservation solutions.
Regional Market Positioning :
Rest of Latin America represents a smaller but growing portion of the broader Latin American organ preservation landscape, with expansion potential as healthcare systems modernize and transplant capabilities increase.
Growth Drivers :
Increasing organ transplant program expansion, rising healthcare spending, and growing awareness of organ preservation technologies are key factors supporting the 3.7% CAGR in Rest of Latin America through 2030.
Rest Of Latin America Organ Preservation Market Dynamics
- The 3.7% CAGR reflects a developing market with increasing investment in advanced medical technologies and growing recognition of organ preservation's critical role in improving transplant outcomes. Future growth will be driven by enhanced healthcare funding, expansion of transplant centers, and adoption of innovative preservation solutions.
- As regional healthcare capabilities strengthen and transplant programs mature, demand for organ preservation technologies is expected to accelerate, creating opportunities for market participants to establish presence in this emerging segment..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Rolatam's organ preservation market is valued at USD 1.51 million in 2025 with a projected value of USD 1.81 million by 2030.
- Rolatam is experiencing a 3.7% CAGR, reflecting steady but moderate growth compared to global expansion rates.
- Rolatam's market growth is driven by healthcare infrastructure modernization and increased transplant program capacity.
- Rolatam represents an emerging opportunity within Latin America's organ preservation sector with rising international partnerships.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
Rest Of Latin America Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Evaluate market entry opportunities and expansion strategies in Rest of Latin America's organ preservation segment to capture growing demand from emerging transplant programs and modernizing healthcare facilities.
- Healthcare System Administrators : Understand regional market trends and technology adoption patterns to make informed procurement decisions for organ preservation solutions that align with infrastructure development and transplant program expansion goals.
- Investment & Private Equity Firms : Assess investment potential in Rest of Latin America's healthcare sector, identifying growth opportunities in organ preservation technology companies and transplant infrastructure development with 3.7% CAGR potential.
- Transplant Center Directors : Access market intelligence on available organ preservation technologies, regional adoption trends, and competitive solutions to optimize transplant program capabilities and improve patient outcomes in Rest of Latin America.
- Healthcare Consultants & Analysts : Leverage regional market data and forecasts to provide clients with actionable insights on organ preservation market dynamics, growth drivers, and strategic opportunities specific to Rest of Latin America's healthcare landscape.
Key Companies in the Rest Of Latin America Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- Emerging Market Opportunity : Identify early-stage growth opportunities in Rest of Latin America's developing organ preservation segment before market maturation, positioning your organization ahead of competitors in an expanding healthcare sector.
- Regional Market Dynamics : Gain detailed insights into Rest of Latin America-specific factors driving the 3.7% CAGR, including healthcare infrastructure investments, transplant program expansion, and regional adoption patterns distinct from broader Latin American trends.
- Strategic Market Entry : Develop informed market entry strategies tailored to Rest of Latin America's unique healthcare landscape, regulatory environment, and transplant infrastructure development stage to maximize investment returns.
- Competitive Intelligence : Understand the competitive landscape specific to Rest of Latin America, including key players, market gaps, and opportunities to differentiate your organ preservation solutions in this developing region.
- Growth Forecasting : Access accurate 2025-2030 projections for Rest of Latin America enabling precise financial planning, resource allocation, and long-term strategic decisions for regional expansion and product development.
Frequently asked questions
What is the current market size of organ preservation in Rolatam?
Rolatam's organ preservation market is estimated at USD 1.51 million in 2025.
What is the projected market size for organ preservation in Rolatam by 2030?
Rolatam's organ preservation market is forecast to reach USD 1.81 million by 2030.
What is the growth rate of the organ preservation market in Rolatam?
Rolatam's organ preservation market is growing at a CAGR of 3.7% from 2025 to 2030.
What factors are driving growth in Rolatam's organ preservation market?
Growth in Rolatam is driven by healthcare infrastructure investments, expanding transplant programs, regulatory support, and increased international partnerships with medical device suppliers.
How does Rolatam's organ preservation market compare to global trends?
Rolatam's 3.7% CAGR is lower than the global 6.8% CAGR, reflecting Rolatam's emerging market status within the Latin American region.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report